A drug which is said to "reboot" the immune system has been shown to be an effective treatment for multiple sclerosis (MS), a study has found.
The results of the trials were so encouraging in reducing the number of attacks in those affected that the MS Society is campaigning for the drug to become available on the NHS.
The research showed that alemtuzumab significantly reduced the number of attacks or relapses by people with MS compared to the current drug interferon beta-1a which is known commercially as Rebif.
More top news
On Wednesday, the rain will roll northwards - a few hours of solid rain in the east and over the Pennines.
Jeremy Corbyn has challenged Theresa May to better fund the police and fire services by backing a Labour amendment to the Queen's Speech.
All 33 London councils were warned about "combustible" panels being used on buildings which could potentially spread blazes.